Company Filing History:
Years Active: 2015-2018
Title: Niam Zhou: Innovator in Cancer Treatment
Introduction
Niam Zhou is a prominent inventor based in College Station, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 3 patents, Zhou is dedicated to improving therapeutic options for cancer patients.
Latest Patents
Zhou's latest patents focus on compositions and methods for drug-sensitization or inhibition of cancer cells. The disclosures provide rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions, which are capable of causing drug-sensitization in cancer cells or directly inhibiting them. The methods outlined in these patents include administering such compositions to cancer cells to enhance their sensitivity to chemotherapeutics or to inhibit their growth. Additionally, the patents describe methods for increasing reactive oxygen species (ROS), particularly superoxides, in cancer cells. Furthermore, they provide techniques for determining whether a cancer will respond to chemotherapeutics and whether to administer rifamycin or a rifamycin derivative based on ROS levels in the cancer cells of a patient.
Career Highlights
Niam Zhou is affiliated with the Texas A&M University System, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to transform cancer treatment protocols and improve patient outcomes.
Collaborations
Zhou collaborates with esteemed colleagues, including James C. Sacchettini and Dwight Baker, who contribute to his research endeavors and help advance the field of cancer therapeutics.
Conclusion
Niam Zhou's contributions to cancer treatment through his innovative patents and research at Texas A&M University System highlight his commitment to improving the lives of cancer patients. His work exemplifies the impact of scientific innovation in the medical field.